Dr Reddys falls on concerns Q3 results may miss estimates

Shares in Dr Reddy's Laboratories fall 2.1 percent on worries the drug maker will post lower-than-expected October-December earnings, due later in the day
  • Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
GeStepAhead master your money SME Special
moneycontrol.com

Home » News » Business

Feb 14, 2013, 02.09 PM | Source: Reuters

Dr Reddy's falls on concerns Q3 results may miss estimates

Shares in Dr Reddy's Laboratories fall 2.1 percent on worries the drug maker will post lower-than-expected October-December earnings, due later in the day

Like this story, share it with millions of investors on M3

Dr Reddys falls on concerns Q3 results may miss estimates

Shares in Dr Reddy's Laboratories fall 2.1 percent on worries the drug maker will post lower-than-expected October-December earnings, due later in the day

Post Your Comments

Share Cancel

Dr Reddys falls on concerns Q3 results may miss estimates
Shares in Dr Reddy's Laboratories fall 2.1 percent on worries the drug maker will post lower-than-expected October-December earnings, due later in the day.

Margins are also expected to see significant erosion, several dealers add.

Dr Reddy's could miss consensus earnings per share (EPS) estimates by 6 percent in the October-December quarter, according to Thomson Reuters StarMine SmartEstimate data, which measures the forecasts from top-ranked analysts against wider forecasts. * StarMine SmartEstimate suggests EPS for the quarter ending December at Rs 26.03 compared with mean estimate of Rs 27.89.

Dr Reddys Labs stock price

On June 24, 2016, Dr Reddys Laboratories closed at Rs 3150.30, down Rs 20.4, or 0.64 percent. The 52-week high of the share was Rs 4382.95 and the 52-week low was Rs 2750.00.


The company's trailing 12-month (TTM) EPS was at Rs 79.39 per share as per the quarter ended March 2016. The stock's price-to-earnings (P/E) ratio was 39.68. The latest book value of the company is Rs 623.30 per share. At current value, the price-to-book value of the company is 5.05.

Ads by Google

Buy, Hold, Sell ? Hear it first on M3
Dr Reddys falls on concerns Q3 results may miss estimates

See all

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login